Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling

计划入组 242 人 · 首次发布于 2018 年 12 月 3 日

Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer

计划入组 14 人 · 首次发布于 2008 年 5 月 23 日

Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer

计划入组 7 人 · 首次发布于 2008 年 9 月 17 日

human leukocyte antigen-G (Hokkaido University)

FX-300

Human leukocyte antigen-binding vaccine（SLK Kliniken Heilbronn）

ANTIGEN LABORATORIES INC.

United States

EicOsis Human Health, Inc.

United States

ABLE HUMAN MOTION S.L.

Spain

Crossbow Therapeutics Doses First Patient in Phase 1 Trial of First-in-Class T-Cell Engager CBX-663

Crossbow Therapeutics Secures $77 Million Series B to Advance TCR-Mimetic Cancer Immunotherapies

FDA Approves First-in-Human Trial for Novel CAR-T Therapy Targeting Neuroblastoma